Abstract
Introduction
there is little available oxygen and the parasites must switch from aerobic respiration to 42 anaerobic respiration. Crucially, the anaerobic metabolic pathways that STHs depend on while in 43 their hosts are unusual and are not used in any host (Klockiewicz et al., 2002) . Inhibiting these 44
anaerobic pathways thus provides a way to attack the parasites while leaving the host unaffected. 45
During aerobic respiration in helminths, the great majority of ATP is made in the mitochondrion 46 (Tielens, 1994; Tielens et al., 1984 Mitchell, 1975) . From UQ, they are ultimately carried to 52
Complex III then IV where they are finally transferred onto oxygen as the terminal electron 53 acceptor (see Fig 1a) . Electron transport is coupled to proton pumping into the inner membrane 54 space of the mitochondrion -this establishes a proton gradient which is used to power the 55 F0F1-ATP synthase (Mitchell, 1961) . When there is insufficient oxygen to accept electrons at 56
Complex IV, or when inhibitors of Complex IV such as cyanide (Antonini et al., 1971; Nicholls 57 et al., 1972) are present, almost all animals stop using the ETC and rely on anaerobic glycolysis 58 to make ATP, generating lactate (Isom et al., 1975; Meyerhof, 1927) . STHs, however, have 59 evolved a different solution that allow them to survive months in the hypoxic host environment. 60
Electrons still enter the ETC at Complex I, Complex I still pumps protons to generate the proton 61 motive force (PMF), and ATP is still made by the F0F1ATPase, powered by the PMF. However, 62 rather than the electrons passing through the ETC to oxygen as the terminal electron acceptor, 63 they exit the ETC immediately downstream of Complex I onto a number of alternative terminal 64 electron acceptors (Fig 1b) (reviewed in Hochachka and Mustafa, 1972; Müller et al., 2012) . 65 This transfer of the electrons out of the ETC and onto alternative electron acceptors requires the 66 quinone-coupled dehydrogenases (Kita, 1992; Ma et al., 1993) . Under aerobic conditions these 67
QDHs act as entry points to the ETC, transferring electrons from their substrates to UQ. 68
Crucially, the reactions catalysed by these QDHs are reversed in anaerobic conditions -they 69 now act as reductases transferring electrons out of the ETC and onto their products. Takamiya et al., 2002) . In this way an entry of electrons into the ETC from a variety of 74 electron donors in aerobic conditions is reversed to provide an exit from the ETC onto a variety 75 of electron acceptors in anaerobic conditions. 76
The unusual ETC wiring used by STHs to survive anaerobic conditions requires an unusual 77 electron carrier, Rhodoquinone (RQ) (Moore and Folkers, 1965) . RQ and UQ are highly related 78 molecules -the sole difference is the presence of an amine group on the quinone ring of RQ 79 (Fig 1d) . This changes the biophysical properties of the quinone ring: while UQ can accept 80 electrons from the QDHs as they flow into the ETC under aerobic conditions, UQ cannot carry 81 electrons of the correct electropotential to drive the reverse reactions in anaerobic conditions 82 (Fioravanti and Kim, 1988; Sato et al., 1972 Like other helminths, C.elegans has previously been shown to make RQ (Takamiya et al., 2002) . 124 We wanted to confirm this and determine whether we could define a simple experimental 125 method to drive C.elegans to carry out similar anaerobic metabolism as that used by parasitic 126 helminths to survive in their hosts. We extracted quinones as described in Methods and as shown 127
in Fig 2a and Second, the pathway we identify for RQ synthesis suggests novel targets for anthelmintics. The 314 finding that the kynurenine pathway is the source of the key precursors for RQ synthesis 315 suggests naively that helminth-specific inhibitors of the kynureninase pathway might act as 316 potent anthelmintics. However, the human gut is likely to be a source of anthranilate and 3HA 317 from host metabolism or from the microbiome and inhibiting production of these molecules in 318 the helminth itself might thus prove ineffective. A more likely target is COQ-2, the enzyme that 319 prenylates the anthranilate or 3HA ring as the first step in RQ synthesis. Again, it is worth 320 drawing an analogy between the synthesis pathways of UQ and MK in bacteria. Clarke, 1996) in the UQ synthesis pathway. RQ synthesis thus appears to require the availability 378 of oxygen for these enzymes, an unexpected result since RQ is preferentially required in 379 anaerobic conditions and is the predominant quinone in helminths living under anaerobic 380 conditions. How might these oxygen-requiring steps be carried out for RQ synthesis? It is 381 possible that the helminth enzymes have evolved so that they can still operate under low oxygen 382
conditions. Other oxygen-using proteins have evolved extremely high oxygen affinity in 383 helminths -for example Ascaris haem is octameric and binds oxygen with ~25,000 times 384 greater affinity than human haem (Minning et al., 1999) . Alternatively, these same enzymatic 385 steps might be carried out by other enzymes in lower oxygen conditions. In E.coli, for example, 386
UbiB and UbiF (reviewed in Kwon and Meganathan, 2009 ) carry out the same hydroxylation 387 modifications to the quinone ring as COQ-6 and CLK-1 in aerobic conditions and mutation of 388 either gene results in a lack of mature UQ in these bacteria. However, under anaerobic 389 conditions, ubiB and ubiF mutants make normal levels of UQ suggesting that other enzymes 390 carry out these reactions in low oxygen conditions (Alexander and Young, 1978) . It is possible 391 that there is an analogous set of enzymes that are required for RQ synthesis in low oxygen 392 conditions -these would carry out similar reactions to COQ-6 and CLK-1 but without the 393 requirement for oxygen. 394
There is thus still much to be discovered about the regulation and the precise pathway of RQ 395 synthesis in helminths. The results presented here provide a firm starting point and the assay we 396 describe for drugs that affect RQ-dependent metabolism may lead to the discovery and 397 development of a new class of anthelmintic drugs. Since resistance to known classes of 398 anthelmintics is widespread among livestock parasites like H.contortus, C.oncophora and 399
A.suum and is rising in human populations (reviewed in Sangster et al., 2018 ), this will prove 400 critical in the control and treatment of these major pathogens. 401
Materials and Methods 403

Worm Strains and Maintenance 404
In addition to the traditional laboratory strain N2, here we include work using strains clk-405 1(qm30), kynu-1(e1003), sdhc-1(tr357), and sdhc-1(tr423). The two sdhc-1 strains were provided 406 by Dr. Peter Roy and all other strains were provided by the Caenorhabditis Genetics Centre. All 407 worms were maintained on NGM agar plates seeded with E. coli OP50 as described elsewhere 408 (Stiernagle, 2006 ) and maintained at 20°C. 409
RQ Tryptophan Anti-Labelling Experiment 410
Escherichia coli (MG1655) was grown overnight at 37 
Quinone Extraction 417
Nematode samples were thawed and lysed via sonication. Quinone extraction solvent containing 418 a 2:1 ratio of chloroform and methanol (Thermo Fisher Optima LC-MS grade) respectively was 419 added to the samples. The organic phase of the sample was collected and then dried using 420 nitrogen gas. Samples were resuspended in a 60:40 acetonitrile and isopropanol solution prior to 421 analysis using APCI LC-MS. 422
Quinone LC-MS analysis 423
Quinones were analyzed by reverse phase chromatography on an Eclipse Plus C-18 RRHD 424 column, 2.1 mM x 50 mm with 1.8 um packing operated in a thermostatted column compartment 425 held at 70°C. Buffer A was 50% MeCN in water, Buffer B was 100% acetone with 0.01% 426 formic acid. Starting conditions were 0.25 mL/min at 50% B. Gradient was 1-minute hold, 427 followed by increase 100% B at 5 minutes, hold 100% B until 7 minutes, then return to 50% B at 428 7.1 minutes and hold until 10 minutes. Samples were introduced from a HTC pal by injection of 429 5 µL sample into a 2 µL loop. Wash 1 was acetonitrile and wash 2 was isopropanol. Samples 430 were ionized using a Multimode ionization source (Agilent) operated in APCI mode, gas temp 
Image-based assays 437
All image-based experiments were conducted on L1 animals which were collected from mixed-438 stage plates and isolated using a 96 well 11 µM Multiscreen Nylon Mesh filter plate (Millipore: 439 S5EJ008M04) as described previously (Spensley et al., 2018 ) to a final concentration of ~100 440 animals per well. They were then incubated in a final concentration of 200 µM potassium 441 cyanide for varying amounts of time. There are two key assays: the acute and the recovery. The 442 acute assay monitors worm movement immediately following exposure to KCN every 5 minutes 443 for a total of 3 hours. The recovery assays involve a KCN incubation of 3, 6, 9, 12, or 18 hours 444 after which the KCN is diluted 6-fold with M9 buffer. Immediately after dilution, worm 445 movement is monitored every 10 minutes for 3 hours. In both assays, worm movement is 446 quantified using an image-based system as previously described (Spensley et al., 2018) . All data 447
were normalized by the fractional mobility score of the M9-only control wells per strain per time 448 point. 449
Drug preparation and Assay assembly 450
Solutions of potassium cyanide (Sigma 60178-25G) were made fresh prior to each experiment in 451 phosphate buffered saline (PBS) and then diluted to a 5 mM stock solution in M9 buffer. 2X 452 working concentrations were then prepared with M9 and the KCN stock solution. Wact-11 453 (Chembridge ID 6222549) was kept frozen as a 100 mM stock in DMSO. Diluted wact-11 stocks 454
were made in DMSO (BioShop DMS666) to a concentration of 3.75 mM and kept frozen until 455 day of use. 10X working concentrations were made with wact-11 stock, M9 buffer, and DMSO. 456
All experiments were prepared to contain 0.8% v/v DMSO to control for any confounding 457 effects of drug solvent. 458
Assays were assembled in flat-bottomed polystyrene 96-well plates (Corning 3997) to a total 459 volume of 100 µL and 40 µL for the acute and recovery assays, respectively. Apart from assays 460 including wact-11 which constituted half KCN solution, 10% wact-11 solution, and 40% worms 461 in buffer, all other assays were comprised of equal parts worms in buffer and KCN solution. 462
Rotenone LC-MS 463
Worms were collected and isolated as described above. A final concentration of 7.5 L1s/10µL 464 was treated with final concentrations of 12.5µL rotenone (Sigma R8875) in 0.8% DMSO and 465 with 0.8% DMSO alone and with 100 µM KCN in M9 or with M9 alone, 20 mL altogether in 40 466 mL plastic containers (Blender Bottle 600271) and were on a shaker for 1hr at room temperature. 467
After 1hr, samples were poured over 0.2 µM Nylaflo nylon filter membranes (PALL 66604) 468 over vacuum and once the supernatant had run through, the filter paper was placed in prepared 469
1.2 mL of 8:1:1 extraction solvent (MeOH, HPLC Grade (SA 34860); H-2O, HPLC Grade 470 (Caledon 8801-7-40); CHCl3, HPLC Grade (SA 650498)) in a 1.5 mL microfuge tube on dry ice. 471 Tubes were inverted 5 times then vortexed. 472
Samples were switched between -80°C and -20°C three times. Filters were then removed, and 473 the tubes spun at 13,200 rpm at 4°C for 30 min. 1 mL of supernatant was transferred to a new 474 tube and dried under dry N2 with <0.02% O2 at 5 PSI for 8 hrs. Each sample was reconstituted 475 with 30 µL HPLC grade water as was prepared labelled yeast reference. Samples and reference 476 were spun at 13,200 rpm at 4°C for 5 min. 10 µL sample and reference were placed in an LC-MS 477 sample vial (Agilent 5190-2243, cap is Agilent 5185-5820) and were fast spun at 1,000 rpm at 478 4°C. 479
kynu-1 LC-MS 480
N2 and kynu-1(e1003) worms were washed and filtered as previously described. They were then 481 placed in 1.5 mL microfuge tubes at 1.5 mL for a final concentration of 45 L1s, 300 µM KCN in 482 M9 or M9 alone and were placed on a rotator for 6 hours at room temperature. After 6 hours, the 483 samples were extracted and prepared as previously described. 484
Succinate Analysis 485
Succinate was extracted from an IPRP method LC-MS run at an mzCenter of 117.0193 and a 486 retention time of 690 s in the case of the kynu-1 experiment and from an Acid method LC-MS 487 run at an mzCenter of 117.0193 and a retention time of 141 s in the case of the rotenone 488 experiment. Both sets of samples were normalized to a labelled yeast reference. In the case of the 489 kynu-1 experiment, they were further normalized to the median of all the extracted peaks for 490 each sample. In both cases they were ultimately normalized to the mean unlabelled N2 sample 491 treated with buffer or 0.8% DMSO. Plots were generated using {plotPeak}. 492 shown schematically in the top pathway: PHB is prenylated by COQ-2 at the start of the UQ 554 synthesis pathway and RQ either derives from UQ or from a UQ precursor -the amine group is 555 thus added at a late step. The lower pathway shows our proposed pathway. Rather than use PHB 556 as the substrate for COQ-2, RQ synthesis starts with prenylation of anthranilate or 3-557 hydroxyanthranilate by COQ-2 (the 3 hydroxy group is denoted by a red asterisk). The amine 558 group is thus present from the start of RQ synthesis rather than being added at a late step and RQ 559 synthesis proceeds via the same pathway as UQ synthesis. 
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